O

OliPass Corp
KOSDAQ:244460

Watchlist Manager
OliPass Corp
KOSDAQ:244460
Watchlist
Price: 1 651 KRW -13.92% Market Closed
Market Cap: ₩9B

Operating Margin

-1 249.2%
Current
Improving
by 1 181.5%
vs 3-y average of -2 430.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 249.2%
=
Operating Income
₩-8.6B
/
Revenue
₩686.9m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-1 249.2%
=
Operating Income
₩-8.6B
/
Revenue
₩686.9m

Peer Comparison

Country Company Market Cap Operating
Margin
KR
OliPass Corp
KOSDAQ:244460
9B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385.5B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
186.7B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
162.9B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.7B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.6B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.8B USD
Loading...

Market Distribution

Lower than 99% of companies in Korea
Percentile
1st
Based on 2 615 companies
1st percentile
-1 249.2%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

OliPass Corp
Glance View

Market Cap
9B KRW
Industry
Biotechnology

OliPass Corp. develops biological products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2019-09-20. The firm principally manufactures and sells nonopioid analgesic, hyperlipidemia medicine, ocular angiogenesis inhibitor, duchenne dystrophy medicine, cancer immunotherapy medicine and other products. In addition, the Company researches, develops and sells functional cosmetics through the artificial gene platform technology.

Intrinsic Value
904.3 KRW
Overvaluation 45%
Intrinsic Value
Price
O
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-1 249.2%
=
Operating Income
₩-8.6B
/
Revenue
₩686.9m
What is OliPass Corp's current Operating Margin?

The current Operating Margin for OliPass Corp is -1 249.2%, which is above its 3-year median of -2 430.7%.

How has Operating Margin changed over time?

Over the last 3 years, OliPass Corp’s Operating Margin has increased from -1 409.6% to -1 249.2%. During this period, it reached a low of -16 230.6% on Mar 31, 2023 and a high of -237.8% on Dec 31, 2023.

Back to Top